Which condition is treated with ceftizoxime

Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats

Literature

  1. 1.

    Hamilton-Miller, J. M. T., Brumfitt, W., Reynolds, A. V. Cefotaxime (HR 756), a new cephalosporin with exceptional broad-spectrum activityin vitro. J. Antimicrob. Chemother. 4 (1978) 437-444.

    Google Scholar

  2. 2.

    Sosna, J. P., Murray, P. R., Medoff, G. Comparison of thein vitro activities of HR 756 with cephalothin, cefoxitin and cefamandole. Antimicrob. Agents Chemother. 14 (1978) 876-879.

    Google Scholar

  3. 3.

    Knothe, H., Dette, G. A. Thein vitro activity of ceftazidime against clinically important pathogens. J. Antimicrob. Chemother. 8 Suppl. B (1981) 33-41.

    Google Scholar

  4. 4.

    Bint, A. J., Yeoman, P., Kilburn, P., Anderson, R., Stansfield, E. Thein vitro activity of ceftazidime compared with that of other cephalosporins. J. Antimicrob. Chemother. 8 Suppl. B (1981) 47-51.

    Google Scholar

  5. 5.

    Kamimura, T., Matsumoto, Y., Okada, N., Mine, Y., Nishida, M., Goto, S., Kuwahara, S. Ceftizoxime (FK 749) a new parenteral cephalosporin:in vitro otherin vivo antibacterial activities. Antimicrob. Agents Chemother. 16: 540-548 (1979).

    Google Scholar

  6. 6.

    Investigators' Brochure on HR 221 (1980). Hoechst, West Germany.

  7. 7.

    Commichau, R., Freiesleben, H., Sack, K., Krüger, Ch., Henkel, W. Model for assessment of the activity of antimicrobial agents. In:Williams, J. D., Geddes, E. M. (eds.): Chemotherapy, Vol. 2, Plenum Press, New York 1976, pp. 317-322.

    Google Scholar

  8. 8.

    Sachs, L. Applied Statistics. Springer Verlag, Berlin 1973.

    Google Scholar

  9. 9.

    Ericsson, H. M., Sherris, J. C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol. Microbiol. Scand. Sect. B Suppl. 217 (1971) 65-67.

    Google Scholar

  10. 10.

    Klein, P. Bacteriological basics of chemotherapeutic laboratory practice. Springer Verlag, Berlin 1957.

    Google Scholar

  11. 11.

    Marre, R., Züllich, B., Beck, H., Sack, K. Animal studies on the antibacterial activity of 10 cephalosporins. Zbl. Bakt. Hyg. I, Abt. Orig. A 240 (1978) 529-537.

    Google Scholar

  12. 12.

    Bopp, S., Marre, R., Schulz, E., Sack, K. Animal studies on renal tolerance, pharmacokinetics and therapeutic effectiveness of dibekacin. Medicinal Forsch. 31 (1) (1981) 473-477.

    Google Scholar

  13. 13.

    Investigators' Brochure on HR 756. Hoechst, West Germany.

  14. 14.

    Harding, S. M., Monro, A. J., Thornton, J. E., Ayrton, J., Hogg, M. I. J. The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers. J. Antimicrob. Chemother. 8 Suppl. B (1981) 263-272.

    Google Scholar

  15. 15.

    Noda, K., Suzuki, A., Ohta, H., Furukawa, T., Noguchi, H. Metabolic fate of (14C) -ceftizoxime, a parenteral cephalosporin antibiotic, in rats and dogs. Medicinal Forsch. 30 (II) (1980) 1665-1679.

    Google Scholar

  16. 16.

    Investigators' Brochure on Ceftizoxime. Fujisawa Pharmaceutical Co., Japan.

Download references

Author information

Affiliations

  1. Institute for Medical Microbiology at the Medical University of Lübeck, Ratzeburger Allee 160, D-2400, Lübeck

    Dr. R. Marre, D. Herhahn & Dr. H. Free life

  2. Clinic for Internal Medicine at the Medical University of Lübeck, Ratzeburger Allee 160, D-2400, Lübeck

    Dr. E. Schulz & Prof. Dr. K. Sack

About this article

Cite this article

Marre, R., Herhahn, D., Freiesleben, H. et al. Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats. Infection11, S54-S56 (1983). https://doi.org/10.1007/BF01641108

Download citation

Keywords

  • Escherichia Coli
  • Serum level
  • General Practice
  • Antimicrobial Activity
  • Family Medicine